746 related articles for article (PubMed ID: 15533473)
1. Percutaneous nephrostomy versus indwelling ureteral stents in the management of extrinsic ureteral obstruction in advanced malignancies: are there differences?
Ku JH; Lee SW; Jeon HG; Kim HH; Oh SJ
Urology; 2004 Nov; 64(5):895-9. PubMed ID: 15533473
[TBL] [Abstract][Full Text] [Related]
2. The management of malignant ureteral obstruction treated with ureteral stents.
Ganatra AM; Loughlin KR
J Urol; 2005 Dec; 174(6):2125-8. PubMed ID: 16280741
[TBL] [Abstract][Full Text] [Related]
3. The role of percutaneous nephrostomy in malignant ureteric obstruction.
Wilson JR; Urwin GH; Stower MJ
Ann R Coll Surg Engl; 2005 Jan; 87(1):21-4. PubMed ID: 15720902
[TBL] [Abstract][Full Text] [Related]
4. Systemic chemotherapy in patients with indwelling ureteral stenting.
Oh SJ; Ku JH; Byun SS; Lee SW; Jeon HG; Kim HH
Int J Urol; 2005 Jun; 12(6):548-51. PubMed ID: 15985076
[TBL] [Abstract][Full Text] [Related]
5. Management of extrinsic malignant ureteral obstruction with urinary diversion.
Kanou T; Fujiyama C; Nishimura K; Tokuda Y; Uozumi J; Masaki Z
Int J Urol; 2007 Aug; 14(8):689-92. PubMed ID: 17681056
[TBL] [Abstract][Full Text] [Related]
6. 15-year experience with the management of extrinsic ureteral obstruction with indwelling ureteral stents.
Chung SY; Stein RJ; Landsittel D; Davies BJ; Cuellar DC; Hrebinko RL; Tarin T; Averch TD
J Urol; 2004 Aug; 172(2):592-5. PubMed ID: 15247739
[TBL] [Abstract][Full Text] [Related]
7. Wire-reinforced ureteral stents to rescue from nephrostomy tube in extrinsic ureteral obstruction.
Dauw CA; Faerber GJ; Hollingsworth JM; Wolf JS
Can J Urol; 2015 Jun; 22(3):7806-10. PubMed ID: 26068630
[TBL] [Abstract][Full Text] [Related]
8. Ureteral metal stents: 10-year experience with malignant ureteral obstruction treatment.
Liatsikos EN; Karnabatidis D; Katsanos K; Kallidonis P; Katsakiori P; Kagadis GC; Christeas N; Papathanassiou Z; Perimenis P; Siablis D
J Urol; 2009 Dec; 182(6):2613-7. PubMed ID: 19836807
[TBL] [Abstract][Full Text] [Related]
9. Prognostic model for predicting survival after palliative urinary diversion for ureteral obstruction: analysis of 140 cases.
Ishioka J; Kageyama Y; Inoue M; Higashi Y; Kihara K
J Urol; 2008 Aug; 180(2):618-21; discussion 621. PubMed ID: 18554655
[TBL] [Abstract][Full Text] [Related]
10. [Relief of upper urinary tract obstruction in patients with cancer of the prostate].
Kraemer PC; Borre M
Ugeskr Laeger; 2009 Mar; 171(11):873-6. PubMed ID: 19278608
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous nephrostomy versus indwelling ureteral stent in the management of gynecological malignancies.
Song Y; Fei X; Song Y
Int J Gynecol Cancer; 2012 May; 22(4):697-702. PubMed ID: 22315095
[TBL] [Abstract][Full Text] [Related]
12. Endourologic treatments of distal ureteral obstruction in patients with history of pelvic malignancies: efficacy and safety evaluation.
Wen XQ; Gao X; Zhang Y; Cai YB; Qiu JG; Situ J; Zhan HL; Wang DJ
Ai Zheng; 2007 Nov; 26(11):1227-30. PubMed ID: 17991323
[TBL] [Abstract][Full Text] [Related]
13. Retrograde ureteral stents for extrinsic ureteral obstruction: nine years' experience at University of Michigan.
Rosevear HM; Kim SP; Wenzler DL; Faerber GJ; Roberts WW; Wolf JS
Urology; 2007 Nov; 70(5):846-50. PubMed ID: 18068437
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and complications of urinary drainage procedures in idiopathic retroperitoneal fibrosis complicated by extrinsic ureteral obstruction.
Mertens S; Zeegers AG; Wertheimer PA; Hendriksz TR; van Bommel EF
Int J Urol; 2014 Mar; 21(3):283-8. PubMed ID: 24033464
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous nephrostomy versus indwelling ureteral stents in patients with bilateral nongenitourinary malignant extrinsic obstruction.
Park DS; Park JH; Lee YT
J Endourol; 2002 Apr; 16(3):153-4. PubMed ID: 12028623
[TBL] [Abstract][Full Text] [Related]
16. Serum creatinine predicts success in retrograde ureteral stent placement in patients with pelvic malignancies.
McCullough TC; May NR; Metro MJ; Ginsberg PC; Jaffe JS; Harkaway RC
Urology; 2008 Aug; 72(2):370-3. PubMed ID: 18336878
[TBL] [Abstract][Full Text] [Related]
17. Complications of percutaneous nephrostomy in the treatment of malignant ureteral obstructions: single-centre review.
Carrafiello G; Laganà D; Mangini M; Lumia D; Recaldini C; Bacuzzi A; Marconi A; Mira A; Cuffari S; Fugazzola C
Radiol Med; 2006 Jun; 111(4):562-71. PubMed ID: 16779542
[TBL] [Abstract][Full Text] [Related]
18. Ureteric stents vs percutaneous nephrostomy for initial urinary drainage in children with obstructive anuria and acute renal failure due to ureteric calculi: a prospective, randomised study.
ElSheemy MS; Shouman AM; Shoukry AI; ElShenoufy A; Aboulela W; Daw K; Hussein AA; Morsi HA; Badawy H
BJU Int; 2015 Mar; 115(3):473-9. PubMed ID: 24698195
[TBL] [Abstract][Full Text] [Related]
19. Predicting the success of retrograde stenting for managing ureteral obstruction.
Yossepowitch O; Lifshitz DA; Dekel Y; Gross M; Keidar DM; Neuman M; Livne PM; Baniel J
J Urol; 2001 Nov; 166(5):1746-9. PubMed ID: 11586215
[TBL] [Abstract][Full Text] [Related]
20. Role of percutaneous nephrostomy (PCN) in malignant ureteral obstruction.
Jalbani MH; Deenari RA; Dholia KR; Oad AK; Arbani IA
J Pak Med Assoc; 2010 Apr; 60(4):280-3. PubMed ID: 20419970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
